tradingkey.logo
tradingkey.logo
Search

IGC Pharma Inc

IGC
Add to Watchlist
0.249USD
-0.001-0.28%
Close 07-31 16:00ETQuotes delayed by 15 min
25.99MMarket Cap
LossP/E TTM

IGC Financials

See IGC Pharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

IGC Pharma Inc Earnings Date

Latest Release
May 22, 2026
EPS / Forecast
-0.02/-0.02
Revenue / Forecast
328.00K/326.00K
Period
FY2025 Earnings
Revenue(YoY)
869.00K
-35.39%
EPS(YoY)
-0.05
78.88%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q4
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-220.71%-0.02
10.89%-0.02
41.03%-0.02
66.51%-0.02
73.14%-0.02
49.96%-0.02
16.45%-0.03
40.86%-0.04
-106.94%-0.09
---0.05
---0.04
---0.08
---0.04
----
----
----
----
----
----
----
Revenue
-9.43%317.00K
-53.64%191.00K
20.59%328.00K
11.86%330.00K
25.98%257.00K
41.58%412.00K
-50.99%272.00K
77.71%295.00K
-38.55%204.00K
44.06%291.00K
161.79%555.00K
36.07%166.00K
133.80%332.00K
260.71%202.00K
175.32%212.00K
50.62%122.00K
31.48%142.00K
-55.20%56.00K
-86.82%77.00K
179.31%81.00K
Net Profit
-230.85%-2.40M
-6.06%-1.82M
32.76%-1.60M
58.51%-1.20M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
28.41%-2.88M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
38.03%-4.03M
5.54%-2.25M
43.78%-2.44M
-55.76%-2.79M
-120.52%-6.50M
-2.50%-2.38M
-162.16%-4.34M
4.99%-1.79M
6.50%-2.95M
Net Margin
-265.30%-757.73%
-128.77%-953.40%
44.24%-487.50%
62.91%-362.73%
74.02%-711.67%
50.52%-416.75%
-133.84%-874.26%
59.72%-977.97%
-304.44%-2739.71%
---842.27%
---373.87%
---2427.71%
---677.41%
----
----
----
----
----
----
----
Gross Margin
38.01%17.35%
7.85%51.83%
-21.65%46.95%
-19.49%46.67%
-37.93%40.47%
-19.63%48.06%
30.43%59.93%
52.74%57.97%
112.21%65.20%
--59.79%
--45.95%
--37.95%
--30.72%
----
----
----
----
----
----
----
Debt to assets ratio
623.59%9.98%
4.88%1.40%
30.50%1.71%
10.78%1.57%
20.51%1.51%
54.70%1.33%
43.80%1.31%
68.66%1.41%
74.54%1.25%
--0.86%
--0.91%
--0.84%
--0.72%
----
----
----
----
----
----
----
Revenue
-9.43%317.00K
-53.64%191.00K
20.59%328.00K
11.86%330.00K
25.98%257.00K
41.58%412.00K
-50.99%272.00K
77.71%295.00K
-38.55%204.00K
44.06%291.00K
161.79%555.00K
36.07%166.00K
133.80%332.00K
260.71%202.00K
175.32%212.00K
50.62%122.00K
31.48%142.00K
-55.20%56.00K
-86.82%77.00K
179.31%81.00K
Operating profit
15.97%-2.46M
-62.61%-2.90M
19.75%-1.90M
26.30%-1.41M
16.72%-1.88M
28.87%-1.78M
-11.85%-2.37M
47.69%-1.92M
1.01%-2.25M
-0.80%-2.51M
24.38%-2.12M
41.59%-3.66M
4.85%-2.28M
42.37%-2.49M
-27.71%-2.80M
-124.69%-6.27M
-2.92%-2.39M
-157.58%-4.32M
-13.62%-2.19M
-14.24%-2.79M
Net Profit
-230.85%-2.40M
-6.06%-1.82M
32.76%-1.60M
58.51%-1.20M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
28.41%-2.88M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
38.03%-4.03M
5.54%-2.25M
43.78%-2.44M
-55.76%-2.79M
-120.52%-6.50M
-2.50%-2.38M
-162.16%-4.34M
4.99%-1.79M
6.50%-2.95M
Current assets
-35.92%1.15M
-52.85%2.00M
-51.15%2.15M
-21.84%2.90M
-14.85%3.05M
-30.52%4.25M
-13.21%4.41M
-42.70%3.71M
-61.70%3.58M
--6.12M
-60.10%5.08M
-57.21%6.47M
-51.37%9.35M
----
-42.65%12.73M
-35.74%15.11M
68.44%19.24M
58.57%21.70M
38.67%22.19M
32.44%23.52M
Total current liabilities
33.26%2.87M
-45.97%1.51M
-30.70%1.73M
-3.55%2.26M
37.24%2.66M
33.05%2.80M
16.80%2.49M
23.29%2.34M
42.77%1.94M
--2.11M
28.45%2.13M
-22.24%1.90M
6.02%1.36M
----
-21.45%1.66M
3.08%2.44M
-33.32%1.28M
6.16%2.02M
-8.93%2.11M
21.69%2.37M
Total assets
-5.43%9.19M
-6.04%9.74M
-25.02%7.94M
-11.66%8.75M
-19.37%9.08M
-37.18%10.37M
-32.41%10.59M
-42.36%9.90M
-43.90%11.26M
--16.51M
-35.14%15.67M
-35.98%17.18M
-35.85%20.07M
----
-29.84%24.17M
-25.18%26.83M
29.49%31.29M
28.43%33.84M
21.71%34.44M
23.75%35.87M
Total liabilities
33.86%3.06M
-44.82%1.65M
-31.28%1.86M
-6.35%2.42M
27.79%2.82M
24.25%2.99M
9.83%2.71M
13.85%2.58M
25.84%2.21M
--2.41M
16.23%2.47M
-22.94%2.27M
-3.31%1.75M
----
-21.46%2.13M
-3.98%2.94M
-32.63%1.81M
-6.11%2.58M
-21.22%2.71M
25.21%3.06M
Total equity
-17.54%6.12M
9.69%8.09M
-22.87%6.08M
-13.54%6.33M
-30.86%6.26M
-47.67%7.38M
-40.31%7.88M
-50.90%7.32M
-50.58%9.05M
--14.10M
-40.10%13.20M
-37.59%14.91M
-37.86%18.32M
----
-30.55%22.04M
-27.17%23.89M
37.27%29.48M
32.45%31.26M
27.65%31.74M
23.61%32.80M
Net operating income
0.00%-1.22M
-109.84%-2.09M
19.69%-1.41M
-38.78%-730.00K
17.01%-1.32M
38.44%-996.00K
-19.35%-1.75M
65.33%-526.00K
3.70%-1.59M
4.03%-1.62M
33.15%-1.47M
-71.03%-1.52M
31.96%-1.65M
26.76%-1.69M
-18.64%-2.20M
64.59%-887.00K
-31.27%-2.42M
6.50%-2.30M
53.59%-1.85M
-25.69%-2.50M
Net investment
25.44%-170.00K
-475.38%-374.00K
542.75%580.00K
56.04%-142.00K
-70.49%-104.00K
-190.28%-65.00K
-2520.00%-131.00K
-33.47%-323.00K
-258.82%-61.00K
-60.44%72.00K
96.84%-5.00K
56.24%-242.00K
65.31%-17.00K
504.44%182.00K
-66.32%-158.00K
-128.68%-553.00K
-102.96%-49.00K
-104.78%-45.00K
91.64%-95.00K
360.19%1.93M
Net financing
-43.83%710.00K
291.69%3.11M
-66.06%851.00K
20.69%805.00K
34600.00%345.00K
-72.23%794.00K
250800.00%2.51M
66800.00%667.00K
---1.00K
2702.94%2.86M
0.00%-1.00K
0.00%-1.00K
100.00%0.00
-97.02%102.00K
-100.14%-1.00K
-100.01%-1.00K
---1.00K
6936.00%3.42M
25.17%726.00K
18487.01%14.16M

FAQs

What is the total revenue of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its total revenue reached 869.00K, with a year-on-year change of 1.34M.

What are the current assets of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its current assets were 1.79M, with a year-on-year change of -51.69.

What are the total assets of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its total assets of IGC Pharma Inc were 9.71M, with a year-on-year change of -1.92.

What are the total liabilities of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its total liabilities of IGC Pharma Inc were 2.29M, with a year-on-year change of -11.31.

What is the total equity of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its total equity of IGC Pharma Inc was 7.42M, with a year-on-year change of 1.39.

What is the net operating income of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its net operating income of IGC Pharma Inc was -7.73M, with a year-on-year change of 12.16.

What is the net investment of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its net investment of IGC Pharma Inc was -22.00K, with a year-on-year change of 93.06.

What is the net financing of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its net financing of IGC Pharma Inc was 5.22M, with a year-on-year change of 48.27.

What is the Earnings Per Share (EPS) of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.05, with a year-on-year change of 78.88.

What is the net income of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its net income was -4.15M, with a year-on-year change of 68.11.

What is the net margin of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its net profit margin was -477.10, with a year-on-year change of 50.64.

What is the gross margin of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its gross margin was 34.18, with a year-on-year change of -37.29.

What is the debt-to-asset ratio of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its debt-to-asset ratio was 1.38, with a year-on-year change of -2.41.

What is the Return on Equity (ROE) of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -104.33, with a year-on-year change of 10.79.

What is the Return on Assets (ROA) of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -76.37, with a year-on-year change of 20.46.

What is the operating profit of IGC Pharma Inc?

According to IGC Pharma Inc's FY2025 earnings report, its operating profit was -7.73M, with a year-on-year change of 12.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.